Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Use of Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) in Maintaining OAB Symptoms Improvement. [NA]
This document provides an update on a completed trial evaluating whether transcutaneous posterior tibial nerve stimulation can maintain impr…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder
This clinical trial update reports the completion of a study examining the effect of antibiotics on the bladder microbiology of patients wit…
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) [Phase 1]
Phase 1 pharmacokinetic/pharmacodynamic study of vibegron (MK-4618) in women with overactive bladder was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea
A completed Korea-based clinical trial evaluated the safety and efficacy of botulinum toxin type A (BOTOX) for urinary incontinence due to n…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other Antimuscarinics
The completed study evaluated quality of life in patients switched from other antimuscarinics to solifenacin for overactive bladder.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
This clinical trial update reports urinary retention rates observed in real-world practice after treatment with onabotulinumtoxinA for idiop…
-
CLINICAL_TRIALS trial_result · 2016-08-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of Mirabegron compared with Solifenacin in adults with overactive bladder who were unsati…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers [Phase 1]
Phase 1 study evaluating how food affects exposure to fesoterodine fumarate and the pharmacokinetics of its active metabolite 5-Hydroxymethy…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014) [Phase 1]
Phase 1 pharmacokinetics study assessing vibegron (MK-4618) in participants with renal insufficiency to understand dosing considerations.
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients [Phase 4]
Phase 4 safety and efficacy study evaluating botulinum toxin type A (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity…
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder [Phase 3]
This is a Phase 3 clinical trial update evaluating DR-3001 for efficacy and safety in women with overactive bladder. The study, sponsored by…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Tetra-NIRS Clinical Study [Phase 4]
A Phase 4 trial of the Tetra-NIRS device by Laborie Medical Technologies for lower urinary tract symptoms and overactive bladder was termina…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: The Effect of Anticholinergics on Cognitive Function in the Elderly [Phase 4]
A Phase 4 trial evaluating the effect of anticholinergic drugs on cognitive function in elderly participants. The study addresses overactive…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers [Phase 1]
A Phase 1 study evaluated the impact of food on the pharmacokinetics of JLP-1207 in healthy male volunteers; the trial sponsored by Jeil Pha…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. [Phase 1]
This is a Phase 1 pharmacokinetic study of JLP-1207 alone and in combination with solifenacin and tamsulosin in healthy male volunteers. The…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin [Phase 1]
A Phase 1 pharmacokinetic study evaluating potential drug interaction between solifenacin and tamsulosin has been completed. The study was s…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: A Single-Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Adults With Hepatic Insufficiency (MK-4618-013) [Phase 1]
Phase 1 pharmacokinetic study evaluating single-dose Vibegron (MK-4618) in adults with hepatic insufficiency completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) [Phase 2]
Phase 2 study results evaluating the efficacy and safety of Vibegron (MK-4618) in adults with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Vaginal Electrical Stimulation Versus Neuromodulation
A completed clinical trial comparing vaginal electrical stimulation with neuromodulation for overactive bladder that is refractory to other …
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome [Phase 2]
A Phase 2 study evaluating transcutaneous tibial nerve stimulation for overactive bladder (including patients with multiple sclerosis) has c…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: SSR240600C Treatment in Women With Overactive Bladder [Phase 2]
Phase 2 trial update for SSR240600C in women with overactive bladder; the study status is listed as completed.
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Therapy of the Overactive Bladder Syndrome [Phase 4]
A Phase 4 clinical trial evaluating therapy for Overactive Bladder has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: The Effect of Urox™ in the Treatment of Overactive Bladder and Urinary Incontinence [NA]
A completed clinical trial evaluating Urox™ for overactive bladder and urinary incontinence, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of Darifenacin with physiotherapy for overactive bladder in women has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Electrical Nerve Stimulation for Overactive Bladder a Comparison of Treatments [NA]
A clinical trial update comparing electrical nerve stimulation methods for overactive bladder and urge urinary incontinence. The current sta…